Stock Worth Watching: Is ConforMIS Inc a Buy? The Stock Rises Again

Stock Worth Watching: Is ConforMIS Inc a Buy? The Stock Rises Again

The stock of ConforMIS Inc (NASDAQ:CFMS) is a huge mover today! About 793,627 shares traded hands or 162.28% up from the average. ConforMIS Inc (NASDAQ:CFMS) has declined 33.95% since April 4, 2016 and is downtrending. It has underperformed by 35.04% the S&P500.
The move comes after 9 months positive chart setup for the $375.86 million company. It was reported on Nov, 4 by We have $26.44 PT which if reached, will make NASDAQ:CFMS worth $710.38 million more.

Analysts await ConforMIS Inc (NASDAQ:CFMS) to report earnings on November, 7. They expect $-0.35 EPS, up 22.22% or $0.10 from last year’s $-0.45 per share. After $-0.34 actual EPS reported by ConforMIS Inc for the previous quarter, Wall Street now forecasts 2.94% negative EPS growth.

ConforMIS Inc (NASDAQ:CFMS) Ratings Coverage

Out of 9 analysts covering ConforMIS Inc (NASDAQ:CFMS), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. ConforMIS Inc has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. As per Tuesday, August 9, the company rating was maintained by JP Morgan. The firm has “Neutral” rating by JP Morgan given on Friday, May 13. The firm has “Buy” rating given on Monday, July 27 by Canaccord Genuity. The firm has “Market Perform” rating by Wells Fargo given on Friday, May 13. As per Friday, September 16, the company rating was initiated by B. Riley & Co. As per Monday, September 19, the company rating was initiated by SunTrust. JP Morgan initiated the shares of CFMS in a report on Monday, July 27 with “Overweight” rating. Wells Fargo initiated the stock with “Outperform” rating in Monday, July 27 report. As per Tuesday, August 9, the company rating was maintained by Oppenheimer. The stock has “Buy” rating given by Sterne Agee CRT on Tuesday, December 1.

According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.”

More notable recent ConforMIS Inc (NASDAQ:CFMS) news were published by: which released: “ConforMIS Inc (CFMS) Tops Q3 EPS by 5c” on November 03, 2016, also with their article: “Plus the latest data from on 21 home markets across the US” published on May 30, 2015, published: “ConforMIS Inc (CFMS) Appoints New CEO” on October 24, 2016. More interesting news about ConforMIS Inc (NASDAQ:CFMS) were released by: and their article: “ConforMIS Announces Sale of Over 50000 Customized Knee Implants” published on October 04, 2016 as well as‘s news article titled: “ConforMIS Reports Third Quarter 2016 Financial Results” with publication date: November 03, 2016.

CFMS Company Profile

ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped. The Company’s products include iTotal, iTotal PS, iDuo and iUni. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. iFit Design is the Company’s algorithms and computer software that it uses to design customized implants and associated single-use, patient-specific instrumentation, which is referred to as iJigs. iJigs is based on a computed tomography (CT) scan of the patient and to prepare a surgical plan customized for the patient that it calls iView. iFit Printing is a three-dimensional (3D) printing technology that the Company uses to manufacture iJigs. iFit Just-in-Time Delivery is its just-in-time manufacturing and delivery capability. The Firm markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment